Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions of individuals with actinic keratoses (AK), rough, scaly patches of skin caused by cumulative UV exposure, the path to preventing skin cancer can seem like a destructive ordeal. Current…
Read the full articleYou might also wanna read
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
drugdiscoverytrends.com·2d ago
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
STAT·5h ago
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·6h ago
STAT+: 931 days. The drug approval scandal hiding in plain sight
STAT·10h ago
STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug
STAT·11h ago
STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccines
STAT·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.